Page last updated: 2024-10-23

bepridil and Cardiomyopathies, Primary

bepridil has been researched along with Cardiomyopathies, Primary in 2 studies

Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.

Research Excerpts

ExcerptRelevanceReference
"Bepridil (10 mg/kg) was injected twice daily for 15 and 30 days."1.27Comparison of verapamil and bepridil in the therapy of familiar cardiomyopathy of the Syrian hamster. ( Hofmann, U; Kunkel, B; Mutschler, M, 1987)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Amsterdam, FT1
Punt, NC1
Haas, M1
Zaagsma, J1
Kunkel, B1
Hofmann, U1
Mutschler, M1

Other Studies

2 other studies available for bepridil and Cardiomyopathies, Primary

ArticleYear
Stereoisomers of calcium antagonists distinguish a myocardial and vascular mode of protection against cardiac ischemic injury.
    Journal of cardiovascular pharmacology, 1990, Volume: 15, Issue:2

    Topics: Animals; Bepridil; Calcium Channel Blockers; Cardiomyopathies; Coronary Circulation; Coronary Diseas

1990
Comparison of verapamil and bepridil in the therapy of familiar cardiomyopathy of the Syrian hamster.
    Zeitschrift fur Kardiologie, 1987, Volume: 76 Suppl 3

    Topics: Animals; Bepridil; Calcium; Cardiomyopathies; Cricetinae; Muscles; Necrosis; Osmolar Concentration;

1987